SEC Form 4 · accession 0001179110-17-012802
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xiaodong Wang
Director
Period of report
Sep 27, 2017
Accepted (ET)
Oct 2, 2017 · 6:41 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Sep 27, 2017 | A | 410,000 | $0.00 | A | 12,935,393 | D | |
| Ordinary SharesF2 | holding | — | — | — | 214,531 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F3,F4 | $7.70 | Sep 27, 2017 | A | 750,000 | A | — | Sep 26, 2027 | Ordinary Shares | 750,000 | 750,000 | D |
Explanation of responses
- F1Represents securities underlying restricted share units ("RSUs"). 1/4th of the securities will vest on each anniversary of June 30, 2017, subject to continued service.
- F2These securities are held in a UTMA account for Reporting Person's minor child, for which Reporting Person disclaims beneficial ownership.
- F3The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares.
- F4These securities vest over a four-year period as follows: 25% on June 30, 2018, and the remaining in 36 successive equal monthly installments, subject to continued service.